Tracking Cathie Wood's ARK Invest 13F Portfolio - Q4 2025 Update
Source: SeekingAlpha
2026-02-12 22:37:04 ET
This article is part of a series that provides an ongoing analysis of the changes made to ARK Invest’ 13F portfolio on a quarterly basis. It is based on their regulatory 13F Form filed on 02/11/2026....
Read the full article on Seeking Alpha
For further details see:
Tracking Cathie Wood's ARK Invest 13F Portfolio - Q4 2025 Update
Beam Therapeutics Inc.
NASDAQ: BEAM
BEAM Trading
-0.58% G/L:
$27.20 Last:
395,042 Volume:
$27.40 Open:
BEAM Latest News
February 24, 2026 07:01:00 am
Beam Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Announces New Liver-Targeted Genetic Disease Program in Phenylketonuria (PKU)
February 24, 2026 07:00:00 am
Beam Therapeutics Announces $500 Million Strategic Financing Facility with Sixth Street
BEAM Stock Data
$2,726,631,745
90,820,075
0.13%
130
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
